Eclipse Resources and Kite Pharma price IPOs
Eclipse Resources offered 30.3 million shares and the offering priced at $27 per share, at the low end of its estimates. Excluding discounts, expenses, and shares being sold by company stockholders, the company said it will get $545.2 million in proceeds.
Shares of Eclipse Resources Corp. fell $1.03, or 3.8 percent, to $25.97 in morning trading.
Kite Pharma Inc. raised $127.5 million before expenses and discounts, as its initial public offering of 7.5 million shares priced at $17 each.
Shares of the clinical-stage biotechnology company climbed $9.50, or 55.9 percent, to $26.50.
(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)